Baffert, Fabienne <br/><br/>
Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805.  [electronic resource] 

 -  Molecular cancer therapeutics  Jul 2010 
 - 1945-55 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-10-0053  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--pharmacology<br/>Animals<br/>Apoptosis--drug effects<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Erythropoiesis--drug effects<br/>Humans<br/>Janus Kinase 2--antagonists & inhibitors<br/>K562 Cells<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, SCID<br/>Models, Molecular<br/>Molecular Structure<br/>Mutation<br/>Phosphorylation--drug effects<br/>Polycythemia--metabolism<br/>Protein Structure, Tertiary<br/>Quinoxalines--chemistry<br/>Rats<br/>STAT5 Transcription Factor--metabolism<br/>Splenomegaly--metabolism